Verifying…
Home / Drug A–Z / Xl Care Medix Sildenafil Citrate 100 mg Tablets

Xl Care Medix Sildenafil Citrate 100 mg Tablets

NAFDAC Reg. No. A4-101143 · Drug

Registered with NAFDAC. Registration activeAs of 27 October 2026 · synced automatically from official sources.
Product
Xl Care Medix Sildenafil Citrate 100 mg Tablets
NAFDAC number
A4-101143
Active ingredient
Sildenafil (Sildenafil Citrate)
Strength
100 mg
Form
Tablet
Pack size
1 x 5's (in Alu-PVC blister)
Manufacturer
Not listed
Applicant (holder)
XL Care Medix Ltd
Approved
30 Jan 2025
Status
Active View on NAFDAC ↗
Registration valid to
29 Jan 2030
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Xl Care Medix Sildenafil Citrate 100 mg Tablets is on the NAFDAC register with an active registration (A4-101143). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What Xl Care Medix Sildenafil Citrate 100 mg Tablets is used for

From the official U.S. FDA label for sildenafil (sildenafil citrate), the active ingredient registered with NAFDAC.

What it is used for

Sildenafil citrate is indicated for the treatment of erectile dysfunction. Sildenafil citrate is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) ( 1 )

Possible side effects

The following are discussed in more detail in other sections of the labeling: Cardiovascular [ see Warnings and Precautions ( 5.1 ) ] Prolonged Erection and Priapism [ see Warnings and Precautions ( 5.2 ) ] Effects on the Eye [ see Warnings and Precautions ( 5.3 ) ] Hearing Loss [ see Warnings and Precautions ( 5.4 ) ] Hypotension when Co-administered with Alpha-blockers or Anti-hypertensives [ see Warnings and Precautions ( 5.5 ) ] Adverse Reactions with the Concomitant Use of Ritonavir [ see Warnings and Precautions ( 5.6 ) ] Combination with other PDE5 Inhibitors or Other Erectile Dysfunction Therapies [ see Warnings and Precautions ( 5.7 ) ] Effects on Bleeding [ see Warnings and Precaut …

Do not use if

Administration of sildenafil tablets to patients using nitric oxide donors, such as organic nitrates or organic nitrites in any form. Sildenafil citrate was shown to potentiate the hypotensive effect of nitrates ( 4.1 , 7.1 , 12.2 ) Known hypersensitivity to sildenafil or any component of tablet ( 4.2 ) Administration with guanylate cyclase (GC) stimulators, such as riociguat ( 4.3 ) 4.1 Nitrates Consistent with its known effects on the nitric oxide/cGMP pathway [ see Clinical Pharmacology ( 12. …

Warnings

Patients should not use sildenafil tablets if sexual activity is inadvisable due to cardiovascular status ( 5.1 ) Patients should seek emergency treatment if an erection lasts >4 hours. Use sildenafil tablets with caution in patients predisposed to priapism ( 5.2 ) Patients should stop sildenafil tablets and seek medical care if a sudden loss of vision occurs in one or both eyes, which could be a sign of non arteritic anterior ischemic optic neuropathy (NAION). Sildenafil tablets should be used with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION. Patients with a “crowded” optic disc may also be at an increased risk of NAION. …

Pregnancy & breastfeeding

8.1 Pregnancy Risk Summary Sildenafil tablets are not indicated for use in females. There are no data with the use of sildenafil citrate in pregnant women to inform any drug-associated risks for adverse developmental outcomes. Animal reproduction studies conducted with sildenafil did not show adverse developmental outcomes when administered during organogenesis in rats and rabbits at oral doses up to 16 and 32 times, respectively, the maximum rec …

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

NAFDAC recall & alert notices

Public Alert No. 033/2024 – Alert on the Recall of Radox Care + Moisturise Liquid Hand Wash due to presence of Butyphenyl Methylpropional (BMHCA) Content22 Aug 2024 · nafdac.gov.ngThe National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of Radox Care + Moisturise Liquid Hand Wash by the European Union (EU) in Brussels, Belgium.The product does not comply with the Cosmetic Products Regulation as it is said to contain Butyphenyl Methylpropion…Public Alert No.022/2021 – Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators – Letter to Health Care Personnel and Facilities8 Jul 2021 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that the U.S. Food and Drug Administration (FDA) is recommending health care personnel and facilities to transition away from crisis capacity conservation strategies, such as using non-NIOSH-approved disposable respirators, in…Important Covid-19 Vaccine Safety Communication To Healthcare Providers27 May 2021 · nafdac.gov.ng, Important Covid-19 Vaccine Safety Communication To Healthcare Providers KEY POINTS    Possible Rare Event, Severe Allergic Reactions (Anaphylaxis) and Thromboembolic Events with Some Covid-19 Vaccines (probably due to underlying medical conditions and use of certain medications). Possible contraindications with Non…Public Alert No: 39/2020 – Alert on Happy Ducts Compress, Cord Care and Goldenseal Powder by WishGarden Herbs Due to Bacterial Contamination30 Dec 2020 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from the US FDA about voluntary recall of some lots of Happy Ducts Compress, Cord Care and Goldenseal Powder by WishGarden Herbs. The recall is due to a possible supply chain contamination with the bacteria Cronobacter …

Compare the brands and batch numbers in these notices with your pack, or enter your batch number above.

Check your pack of Xl Care Medix Sildenafil Citrate 100 mg Tablets

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Xl Care Medix Sildenafil Citrate 100 mg Tablets

What is in Xl Care Medix Sildenafil Citrate 100 mg Tablets?

Xl Care Medix Sildenafil Citrate 100 mg Tablets contains Sildenafil (Sildenafil Citrate) (100 mg), as tablet, according to its NAFDAC registration record.

Is Xl Care Medix Sildenafil Citrate 100 mg Tablets registered with NAFDAC?

Yes. Xl Care Medix Sildenafil Citrate 100 mg Tablets is listed on the NAFDAC register under registration number A4-101143, and its registration is active as of 27 October 2026.

Has Xl Care Medix Sildenafil Citrate 100 mg Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Xl Care Medix Sildenafil Citrate 100 mg Tablets in our automatically synced alert list.

How can I check that my pack of Xl Care Medix Sildenafil Citrate 100 mg Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-101143, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Xl Care Medix Sildenafil Citrate 100 mg Tablets used for?

Sildenafil citrate is indicated for the treatment of erectile dysfunction. Sildenafil citrate is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) ( 1 ) (Summarised from the official U.S. FDA label for sildenafil (sildenafil citrate). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Xl Care Medix Sildenafil Citrate 100 mg Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.